OpenURL Connection Search

Select item for more details and to access through your institution.

Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients.
Published in:
Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7565, doi. 10.1007/s00432-023-04678-2
By:
- Rimini, Margherita;
- Persano, Mara;
- Tada, Toshifumi;
- Suda, Goki;
- Shimose, Shigeo;
- Kudo, Masatoshi;
- Cheon, Jaekyung;
- Finkelmeier, Fabian;
- Lim, Ho Yeong;
- Presa, José;
- Salani, Francesca;
- Lonardi, Sara;
- Piscaglia, Fabio;
- Kumada, Takashi;
- Sakamoto, Naoya;
- Iwamoto, Hideki;
- Aoki, Tomoko;
- Chon, Hong Jae;
- Himmelsbach, Vera;
- Schirripa, Marta
Publication type:
Article
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study.
Published in:
Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5591, doi. 10.1007/s00432-022-04512-1
By:
- Persano, Mara;
- Rimini, Margherita;
- Tada, Toshifumi;
- Suda, Goki;
- Shimose, Shigeo;
- Kudo, Masatoshi;
- Cheon, Jaekyung;
- Finkelmeier, Fabian;
- Lim, Ho Yeong;
- Rimassa, Lorenza;
- Presa, José;
- Masi, Gianluca;
- Yoo, Changhoon;
- Lonardi, Sara;
- Tovoli, Francesco;
- Kumada, Takashi;
- Sakamoto, Naoya;
- Iwamoto, Hideki;
- Aoki, Tomoko;
- Chon, Hong Jae
Publication type:
Article
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05492-5
By:
- Nakai, Masato;
- Yamamoto, Yoshiya;
- Baba, Masaru;
- Suda, Goki;
- Kubo, Akinori;
- Tokuchi, Yoshimasa;
- Kitagataya, Takashi;
- Yamada, Ren;
- Shigesawa, Taku;
- Suzuki, Kazuharu;
- Nakamura, Akihisa;
- Sho, Takuya;
- Morikawa, Kenichi;
- Ogawa, Koji;
- Furuya, Ken;
- Sakamoto, Naoya
Publication type:
Article
Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.
Published in:
Journal of Gastroenterology, 2010, v. 45, n. 5, p. 523, doi. 10.1007/s00535-009-0162-3
By:
- Nishimura-Sakurai, Yuki;
- Sakamoto, Naoya;
- Mogushi, Kaoru;
- Nagaie, Satoshi;
- Nakagawa, Mina;
- Itsui, Yasuhiro;
- Tasaka-Fujita, Megumi;
- Onuki-Karakama, Yuko;
- Suda, Goki;
- Mishima, Kako;
- Yamamoto, Machi;
- Ueyama, Mayumi;
- Funaoka, Yusuke;
- Watanabe, Takako;
- Azuma, Seishin;
- Sekine-Osajima, Yuko;
- Kakinuma, Sei;
- Tsuchiya, Kiichiro;
- Enomoto, Nobuyuki;
- Tanaka, Hiroshi
Publication type:
Article
A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma.
Published in:
Drugs in R&D, 2017, v. 17, n. 3, p. 381, doi. 10.1007/s40268-017-0187-7
By:
- Takuya Sho;
- Mitsuru Nakanishi;
- Kenichi Morikawa;
- Masatsugu Ohara;
- Naoki Kawagishi;
- Takaaki Izumi;
- Machiko Umemura;
- Jun Ito;
- Masato Nakai;
- Goki Suda;
- Koji Ogawa;
- Makoto Chuma;
- Takashi Meguro;
- Michio Nakamura;
- Atsushi Nagasaka;
- Hiromasa Horimoto;
- Yoshiya Yamamoto;
- Naoya Sakamoto
Publication type:
Article
Prediction Model with HLA-A*33:03 Reveals Number of Days to Develop Liver Cancer from Blood Test.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4761, doi. 10.3390/ijms24054761
By:
- Nishida, Nao;
- Ohashi, Jun;
- Suda, Goki;
- Chiyoda, Takehiro;
- Tamaki, Nobuharu;
- Tomiyama, Takahiro;
- Ogasawara, Sachiko;
- Sugiyama, Masaya;
- Kawai, Yosuke;
- Khor, Seik-Soon;
- Nagasaki, Masao;
- Fujimoto, Akihiro;
- Tsuchiura, Takayo;
- Ishikawa, Miyuki;
- Matsuda, Koichi;
- Yano, Hirohisa;
- Yoshizumi, Tomoharu;
- Izumi, Namiki;
- Hasegawa, Kiyoshi;
- Sakamoto, Naoya
Publication type:
Article
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis.
Published in:
Journal of Medical Virology, 2023, v. 95, n. 2, p. 1, doi. 10.1002/jmv.28452
By:
- Suda, Goki;
- Baba, Masaru;
- Yamamoto, Yoshiya;
- Sho, Takuya;
- Ogawa, Koji;
- Kimura, Megumi;
- Hosoda, Shunichi;
- Yoshida, Sonoe;
- Kubo, Akinori;
- Fu, Qingjie;
- Yang, Zijian;
- Tokuchi, Yoshimasa;
- Kitagataya, Takashi;
- Maehara, Osamu;
- Ohnishi, Shunsuke;
- Yamada, Ren;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Natsuizaka, Mitsuteru;
- Nakai, Masato
Publication type:
Article
Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infection.
Published in:
Journal of Medical Virology, 2017, v. 89, n. 5, p. 857, doi. 10.1002/jmv.24692
By:
- Tsukuda, Yoko;
- Suda, Goki;
- Tsunematsu, Seiji;
- Ito, Jun;
- Sato, Fumiyuki;
- Terashita, Katsumi;
- Nakai, Masato;
- Sho, Takuya;
- Maehara, Osamu;
- Shimazaki, Tomoe;
- Kimura, Megumi;
- Morikawa, Kenichi;
- Natsuizaka, Mitsuteru;
- Ogawa, Koji;
- Ohnishi, Shunsuke;
- Chuma, Makoto;
- Sakamoto, Naoya
Publication type:
Article
Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A.
Published in:
Journal of Medical Virology, 2017, v. 89, n. 2, p. 267, doi. 10.1002/jmv.24643
By:
- Tsunematsu, Seiji;
- Suda, Goki;
- Yamasaki, Kazushi;
- Kimura, Megumi;
- Izumi, Takaaki;
- Umemura, Machiko;
- Ito, Jun;
- Sato, Fumiyuki;
- Nakai, Masato;
- Sho, Takuya;
- Morikawa, Kenichi;
- Ogawa, Koji;
- Tanaka, Yasuhito;
- Watashi, Koichi;
- Wakita, Takaji;
- Sakamoto, Naoya
Publication type:
Article
Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21315-z
By:
- Kawagishi, Naoki;
- Suda, Goki;
- Sakamori, Ryotaro;
- Matsui, Takeshi;
- Onozawa, Masahiro;
- Yang, Zijian;
- Yoshida, Sonoe;
- Ohara, Masatsugu;
- Kimura, Megumi;
- Kubo, Akinori;
- Maehara, Osamu;
- Fu, Qingjie;
- Hosoda, Shunichi;
- Tokuchi, Yoshimasa;
- Suzuki, Kazuharu;
- Nakai, Masato;
- Sho, Takuya;
- Morikawa, Kenichi;
- Natsuizaka, Mitsuteru;
- Ogawa, Koji
Publication type:
Article
Positivity of high‐sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non‐HBV‐related HCC.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1315, doi. 10.1111/apt.18229
By:
- Yasuura, Naohiro;
- Suda, Goki;
- Ohara, Masatsugu;
- Meno, Akimitsu;
- Sho, Takuya;
- Kohya, Risako;
- Sasaki, Takashi;
- Yoda, Tomoka;
- Yoshida, Sonoe;
- Fu, Qingjie;
- Yang, Zijian;
- Hosoda, Shunichi;
- Maehara, Osamu;
- Ohnishi, Shunsuke;
- Saitou, Tomoya;
- Sugiyama, Masaya;
- Fukuhara, Takasuke;
- Baba, Masaru;
- Kitagataya, Takashi;
- Kawagishi, Naoki
Publication type:
Article
Featured Cover.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 3, p. i, doi. 10.1111/apt.18168
By:
- Kumazaki, Shusuke;
- Hikita, Hayato;
- Tahata, Yuki;
- Sung, Ji Hyun;
- Fukumoto, Kenji;
- Myojin, Yuta;
- Sakane, Sadatsugu;
- Murai, Kazuhiro;
- Sasaki, Yoichi;
- Shirai, Kumiko;
- Saito, Yoshinobu;
- Kodama, Takahiro;
- Kakita, Naruyasu;
- Takahashi, Hirokazu;
- Toyoda, Hidenori;
- Suda, Goki;
- Morii, Eiichi;
- Kojima, Takashi;
- Ebihara, Takeshi;
- Shimizu, Kentaro
Publication type:
Article
Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 3, p. 327, doi. 10.1111/apt.18063
By:
- Kumazaki, Shusuke;
- Hikita, Hayato;
- Tahata, Yuki;
- Sung, Ji Hyun;
- Fukumoto, Kenji;
- Myojin, Yuta;
- Sakane, Sadatsugu;
- Murai, Kazuhiro;
- Sasaki, Yoichi;
- Shirai, Kumiko;
- Saito, Yoshinobu;
- Kodama, Takahiro;
- Kakita, Naruyasu;
- Takahashi, Hirokazu;
- Toyoda, Hidenori;
- Suda, Goki;
- Morii, Eiichi;
- Kojima, Takashi;
- Ebihara, Takeshi;
- Shimizu, Kentaro
Publication type:
Article
Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats.
Published in:
Stem Cells International, 2018, p. 1, doi. 10.1155/2018/3212643
By:
- Ohara, Masatsugu;
- Ohnishi, Shunsuke;
- Hosono, Hidetaka;
- Yamamoto, Koji;
- Yuyama, Kohei;
- Nakamura, Hideki;
- Fu, Qingjie;
- Maehara, Osamu;
- Suda, Goki;
- Sakamoto, Naoya
Publication type:
Article
Etiological changes of liver cirrhosis and hepatocellular carcinoma‐complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021.
Published in:
Hepatology Research, 2024, v. 54, n. 8, p. 763, doi. 10.1111/hepr.14047
By:
- Enomoto, Hirayuki;
- Akuta, Norio;
- Hikita, Hayato;
- Suda, Goki;
- Inoue, Jun;
- Tamaki, Nobuharu;
- Ito, Kiyoaki;
- Akahane, Takemi;
- Kawaoka, Tomokazu;
- Morishita, Asahiro;
- Ogawa, Eiichi;
- Tateishi, Ryosuke;
- Yoshiji, Hitoshi
Publication type:
Article
Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan.
Published in:
Hepatology Research, 2023, v. 53, n. 10, p. 960, doi. 10.1111/hepr.13936
By:
- Sasaki, Takashi;
- Suda, Goki;
- Ohara, Masatsugu;
- Hosoda, Shunichi;
- Kawagishi, Naoki;
- Kohya, Risako;
- Yoda, Tomoka;
- Maehara, Osamu;
- Ohnishi, Shunsuke;
- Yoshida, Sonoe;
- Fu, Qingjie;
- Yang, Zijian;
- Tokuchi, Yoshimasa;
- Kitagataya, Takashi;
- Suzuki, Kazuharu;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Komukai, Sho;
- Ogawa, Koji
Publication type:
Article
Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight.
Published in:
Hepatology Research, 2023, v. 53, n. 7, p. 595, doi. 10.1111/hepr.13899
By:
- Tokuchi, Yoshimasa;
- Suda, Goki;
- Kawagishi, Naoki;
- Ohara, Masatsugu;
- Kohya, Risako;
- Sasaki, Takashi;
- Yoda, Tomoka;
- Maehara, Osamu;
- Ohnishi, Shunsuke;
- Kubo, Akinori;
- Yoshida, Sonoe;
- Fu, Qingjie;
- Yang, Zijian;
- Hosoda, Shunichi;
- Kitagataya, Takashi;
- Suzuki, Kazuharu;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Ogawa, Koji
Publication type:
Article
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon‐lambda 3 induction in chronic hepatitis B patients.
Published in:
Hepatology Research, 2022, v. 52, n. 7, p. 586, doi. 10.1111/hepr.13768
By:
- Umemura, Machiko;
- Ogawa, Koji;
- Morikawa, Kenichi;
- Kubo, Akinori;
- Tokuchi, Yoshimasa;
- Yamada, Ren;
- Kitagataya, Takashi;
- Shigesawa, Taku;
- Shimazaki, Tomoe;
- Kimura, Megumi;
- Suzuki, Kazuharu;
- Nakamura, Akihisa;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Izumi, Takaaki;
- Nakai, Masato;
- Sho, Takuya;
- Suda, Goki;
- Natsuizaka, Mitsuteru;
- Ono, Kota
Publication type:
Article
Overestimated renal function in patients with liver cirrhosis predicts poor prognosis.
Published in:
Hepatology Research, 2022, v. 52, n. 7, p. 603, doi. 10.1111/hepr.13765
By:
- Yoshida, Sonoe;
- Suda, Goki;
- Ohara, Masatsugu;
- Kimura, Megumi;
- Yang, Zijian;
- Maehara, Osamu;
- Fu, Qingjie;
- Hosoda, Shunichi;
- Akinori, Kubo;
- Tokuchi, Yoshimasa;
- Yamada, Ren;
- Kitagataya, Takashi;
- Suzuki, Kazuharu;
- Kawagishi, Naoki;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Morikawa, Kenichi;
- Ogawa, Koji;
- Ohnishi, Shunsuke
Publication type:
Article
The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.
Published in:
Hepatology Research, 2022, v. 52, n. 6, p. 508, doi. 10.1111/hepr.13757
By:
- Nakamura, Akihisa;
- Yamamoto, Koji;
- Takeda, Rei;
- Yamada, Ren;
- Kubo, Akinori;
- Morikawa, Kenichi;
- Ando, Sayaka;
- Shimazaki, Tomoe;
- Izumi, Takaaki;
- Umemura, Machiko;
- Kitagataya, Takashi;
- Shigesawa, Taku;
- Suzuki, Kazuharu;
- Kimura, Megumi;
- Nakai, Masato;
- Sho, Takuya;
- Suda, Goki;
- Natsuizaka, Mitsuteru;
- Ogawa, Koji;
- Ohnishi, Shunsuke
Publication type:
Article
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.
Published in:
Hepatology Research, 2021, v. 51, n. 9, p. 979, doi. 10.1111/hepr.13693
By:
- Sho, Takuya;
- Suda, Goki;
- Ogawa, Koji;
- Kimura, Megumi;
- Kubo, Akinori;
- Tokuchi, Yoshimasa;
- Kitagataya, Takashi;
- Maehara, Osamu;
- Ohnishi, Shunsuke;
- Shigesawa, Taku;
- Nakamura, Akihisa;
- Yamada, Ren;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Natsuizaka, Mitsuteru;
- Nakai, Masato;
- Morikawa, Kenichi;
- Furuya, Ken;
- Baba, Masaru;
- Yamamoto, Yoshiya
Publication type:
Article
Time‐dependent changes in the seroprevalence of COVID‐19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID‐19.
Published in:
Hepatology Research, 2020, v. 50, n. 10, p. 1196, doi. 10.1111/hepr.13551
By:
- Suda, Goki;
- Ogawa, Koji;
- Kimura, Megumi;
- Maehara, Osamu;
- Kitagataya, Takashi;
- Ohara, Masatsugu;
- Tokuchi, Yoshimasa;
- Kubo, Akinori;
- Yamada, Ren;
- Shigesawa, Taku;
- Suzuki, Kazuharu;
- Kawagishi, Naoki;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Morikawa, Kenichi;
- Sakamoto, Naoya
Publication type:
Article
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.
Published in:
Hepatology Research, 2020, v. 50, n. 8, p. 966, doi. 10.1111/hepr.13511
By:
- Sho, Takuya;
- Suda, Goki;
- Ogawa, Koji;
- Shigesawa, Taku;
- Suzuki, Kazuharu;
- Nakamura, Akihisa;
- Ohara, Masatsugu;
- Umemura, Machiko;
- Kawagishi, Naoki;
- Natsuizaka, Mitsuteru;
- Nakai, Masato;
- Morikawa, Kenichi;
- Furuya, Ken;
- Baba, Masaru;
- Ito, Jun;
- Yamamoto, Yoshiya;
- Kobayashi, Tomoe;
- Meguro, Takashi;
- Saga, Akiyoshi;
- Miyagishima, Takuto
Publication type:
Article
Analysis of the optimal psoas muscle mass index cut‐off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people.
Published in:
Hepatology Research, 2020, v. 50, n. 6, p. 715, doi. 10.1111/hepr.13499
By:
- Ohara, Masatsugu;
- Suda, Goki;
- Kimura, Megumi;
- Maehara, Osamu;
- Shimazaki, Tomoe;
- Shigesawa, Taku;
- Suzuki, Kazuharu;
- Nakamura, Akihisa;
- Kawagishi, Naoki;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Morikawa, Kenichi;
- Ogawa, Koji;
- Kobayashi, Tomoe;
- Uebayashi, Minoru;
- Takagi, Ryo;
- Yokota, Isao;
- Shimamura, Tsuyoshi;
- Sakamoto, Naoya
Publication type:
Article
High serum angiopoietin‐2 level predicts non‐regression of liver stiffness measurement‐based liver fibrosis stage after direct‐acting antiviral therapy for hepatitis C.
Published in:
Hepatology Research, 2020, v. 50, n. 6, p. 671, doi. 10.1111/hepr.13490
By:
- Kawagishi, Naoki;
- Suda, Goki;
- Kimura, Megumi;
- Maehara, Osamu;
- Shimazaki, Tomoe;
- Yamada, Ren;
- Kitagataya, Takashi;
- Shigesawa, Taku;
- Suzuki, Kazuharu;
- Nakamura, Akihisa;
- Ohara, Masatsugu;
- Umemura, Machiko;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Morikawa, Kenichi;
- Ogawa, Koji;
- Kudo, Yusuke;
- Nishida, Mutsumi;
- Sakamoto, Naoya
Publication type:
Article
Effects of resistance‐associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs.
Published in:
Hepatology Research, 2019, v. 49, n. 11, p. 1275, doi. 10.1111/hepr.13401
By:
- Suda, Goki;
- Kimura, Megumi;
- Shigesawa, Taku;
- Suzuki, Kazuharu;
- Nakamura, Akihisa;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Nakai, Masato;
- Sho, Takuya;
- Maehara, Osamu;
- Shimazaki, Tomoe;
- Morikawa, Kenichi;
- Natsuizaka, Mitsuteru;
- Ogawa, Koji;
- Sakamoto, Naoya
Publication type:
Article
Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis.
Published in:
Hepatology Research, 2019, v. 49, n. 11, p. 1294, doi. 10.1111/hepr.13399
By:
- Suzuki, Kazuharu;
- Suda, Goki;
- Yamamoto, Yoshiya;
- Furuya, Ken;
- Baba, Masaru;
- Kimura, Megumi;
- Maehara, Osamu;
- Shimazaki, Tomoe;
- Yamamoto, Koji;
- Shigesawa, Taku;
- Nakamura, Akihisa;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Morikawa, Kenichi;
- Ogawa, Koji;
- Sakamoto, Naoya
Publication type:
Article
Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.
Published in:
Hepatology Research, 2019, v. 49, n. 10, p. 1207, doi. 10.1111/hepr.13391
By:
- Izumi, Takaaki;
- Sho, Takuya;
- Morikawa, Kenichi;
- Shigesawa, Taku;
- Suzuki, Kazuharu;
- Nakamura, Akihisa;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Umemura, Machiko;
- Shimazaki, Tomoe;
- Kimura, Megumi;
- Nakai, Masato;
- Suda, Goki;
- Natsuizaka, Mitsuteru;
- Ogawa, Koji;
- Kudo, Yusuke;
- Nishida, Mutsumi;
- Ono, Kota;
- Baba, Masaru;
- Furuya, Ken
Publication type:
Article
Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction.
Published in:
Hepatology Research, 2018, v. 48, n. 7, p. 529, doi. 10.1111/hepr.13056
By:
- Sho, Takuya;
- Suda, Goki;
- Nagasaka, Atsushi;
- Yamamoto, Yoshiya;
- Furuya, Ken;
- Kumagai, Kenichi;
- Uebayashi, Minoru;
- Terashita, Katsumi;
- Kobayashi, Tomoe;
- Tsunematsu, Izumi;
- Onodera, Manabu;
- Meguro, Takashi;
- Kimura, Megumi;
- Ito, Jun;
- Umemura, Machiko;
- Izumi, Takaaki;
- Kawagishi, Naoki;
- Ohara, Masatsugu;
- Ono, Yuji;
- Nakai, Masato
Publication type:
Article
Increased serum C‐reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis.
Published in:
Hepatology Research, 2018, v. 48, n. 3, p. E311, doi. 10.1111/hepr.12988
By:
- Nakai, Masato;
- Ogawa, Koji;
- Takeda, Rei;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Izumi, Takaaki;
- Umemura, Machiko;
- Ito, Jun;
- Sho, Takuya;
- Suda, Goki;
- Morikawa, Kenichi;
- Sakamoto, Naoya
Publication type:
Article
Add‐on effects of fluvastatin in simeprevir/pegylated‐interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study.
Published in:
Hepatology Research, 2018, v. 48, n. 3, p. E146, doi. 10.1111/hepr.12938
By:
- Suda, Goki;
- Ito, Jun;
- Nagasaka, Atsushi;
- Yamamoto, Yoshiya;
- Furuya, Ken;
- Okamoto, Munenori;
- Terashita, Katsumi;
- Kobayashi, Tomoe;
- Tsunematsu, Izumi;
- Yoshida, Junichi;
- Meguro, Takashi;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Kimura, Megumi;
- Umemura, Machiko;
- Izumi, Takaaki;
- Tsukuda, Yoko;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru
Publication type:
Article
Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment.
Published in:
Hepatology Research, 2017, v. 47, n. 11, p. 1127, doi. 10.1111/hepr.12851
By:
- Suda, Goki;
- Nagasaka, Atsushi;
- Yamamoto, Yoshiya;
- Furuya, Ken;
- Kumagai, Kenichi;
- Kudo, Mineo;
- Terashita, Katsumi;
- Kobayashi, Tomoe;
- Tsunematsu, Izumi;
- Yoshida, Junichi;
- Meguro, Takashi;
- Kimura, Megumi;
- Ito, Jun;
- Umemura, Machiko;
- Izumi, Takaaki;
- Tsunematsu, Seiji;
- Sato, Fumiyuki;
- Tsukuda, Yoko;
- Nakai, Masato;
- Sho, Takuya
Publication type:
Article
Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma.
Published in:
Hepatology Research, 2017, v. 47, n. 6, p. 533, doi. 10.1111/hepr.12775
By:
- Tsunematsu, Seiji;
- Suda, Goki;
- Yamasaki, Kazushi;
- Kimura, Megumi;
- Takaaki, Izumi;
- Umemura, Machiko;
- Ito, Jun;
- Sato, Fumiyuki;
- Nakai, Masato;
- Sho, Takuya;
- Morikawa, Kenichi;
- Ogawa, Koji;
- Kamiyama, Toshiya;
- Taketomi, Akinobu;
- Sakamoto, Naoya
Publication type:
Article
Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection.
Published in:
Hepatology Research, 2016, v. 46, n. 13, p. 1294, doi. 10.1111/hepr.12685
By:
- Ito, Jun;
- Suda, Goki;
- Yamamoto, Yoshiya;
- Nagasaka, Atsushi;
- Furuya, Ken;
- Kumagai, Kenichi;
- Kikuchi, Hideaki;
- Miyagishima, Takuto;
- Kobayashi, Tomoe;
- Kimura, Megumi;
- Yamasaki, Kazushi;
- Umemura, Machiko;
- Izumi, Takaaki;
- Tsunematsu, Seiji;
- Sato, Fumiyuki;
- Tsukuda, Yoko;
- Terashita, Katsumi;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru
Publication type:
Article
Viral life cycle of hepatitis B virus: Host factors and druggable targets.
Published in:
Hepatology Research, 2016, v. 46, n. 9, p. 871, doi. 10.1111/hepr.12650
By:
- Morikawa, Kenichi;
- Suda, Goki;
- Sakamoto, Naoya
Publication type:
Article
Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions.
Published in:
Hepatology Research, 2015, v. 45, n. 8, p. 837, doi. 10.1111/hepr.12421
By:
- Suda, Goki;
- Yamamoto, Yoshiya;
- Nagasaka, Astushi;
- Furuya, Ken;
- Kudo, Mineo;
- Chuganji, Yoshimichi;
- Tsukuda, Yoko;
- Tsunematsu, Seiji;
- Sato, Fumiyuki;
- Terasita, Katsumi;
- Nakai, Masato;
- Horimoto, Hiromasa;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Ogawa, Kouji;
- Ohnishi, Shunsuke;
- Chuma, Makoto;
- Fujita, Yasuyuki;
- Abe, Riichiro;
- Taniguchi, Miki
Publication type:
Article
Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication.
Published in:
Hepatology Research, 2009, v. 39, n. 1, p. 60, doi. 10.1111/j.1872-034X.2008.00398.x
By:
- Sekine-Osajima, Yuko;
- Sakamoto, Naoya;
- Nakagawa, Mina;
- Itsui, Yasuhiro;
- Tasaka, Megumi;
- Nishimura-Sakurai, Yuki;
- Cheng-Hsin Chen;
- Suda, Goki;
- Mishima, Kako;
- Onuki, Yuko;
- Yamamoto, Machi;
- Maekawa, Shinya;
- Enomoto, Nobuyuki;
- Kanai, Takanori;
- Tsuchiya, Kiichiro;
- Watanabe, Mamoru
Publication type:
Article
Macrophage-Derived Extracellular Vesicles Induce Long-Lasting Immunity Against Hepatitis C Virus Which Is Blunted by Polyunsaturated Fatty Acids.
Published in:
Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00723
By:
- Cai, Chengcong;
- Koch, Benjamin;
- Morikawa, Kenichi;
- Suda, Goki;
- Sakamoto, Naoya;
- Rueschenbaum, Sabrina;
- Akhras, Sami;
- Dietz, Julia;
- Hildt, Eberhard;
- Zeuzem, Stefan;
- Welsch, Christoph;
- Lange, Christian M.
Publication type:
Article
Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma.
Published in:
Cancers, 2023, v. 15, n. 12, p. 3257, doi. 10.3390/cancers15123257
By:
- Kohya, Risako;
- Suda, Goki;
- Ohara, Masatsugu;
- Sasaki, Takashi;
- Yoda, Tomoka;
- Sakurai, Naofumi;
- Yoshida, Sonoe;
- Fu, Qingjie;
- Yang, Zijian;
- Hosoda, Shunichi;
- Maehara, Osamu;
- Ohnishi, Shunsuke;
- Tokuchi, Yoshimasa;
- Kitagataya, Takashi;
- Suzuki, Kazuharu;
- Kawagishi, Naoki;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Ogawa, Koji
Publication type:
Article
Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma.
Published in:
Cancers, 2023, v. 15, n. 3, p. 593, doi. 10.3390/cancers15030593
By:
- Yang, Zijian;
- Suda, Goki;
- Maehara, Osamu;
- Ohara, Masatsugu;
- Yoda, Tomoka;
- Sasaki, Takashi;
- Kohya, Risako;
- Yoshida, Sonoe;
- Hosoda, Shunichi;
- Tokuchi, Yoshimasa;
- Kitagataya, Takashi;
- Suzuki, Kazuharu;
- Kawagishi, Naoki;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Ogawa, Koji;
- Ohnishi, Shunsuke;
- Sakamoto, Naoya
Publication type:
Article
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.
Published in:
Cancers, 2022, v. 14, n. 16, p. 3938, doi. 10.3390/cancers14163938
By:
- Sho, Takuya;
- Suda, Goki;
- Yamamoto, Yoshiya;
- Furuya, Ken;
- Baba, Masaru;
- Ogawa, Koji;
- Kubo, Akinori;
- Tokuchi, Yoshimasa;
- Fu, Qingjie;
- Yang, Zijian;
- Kimura, Megumi;
- Kitagataya, Takashi;
- Maehara, Osamu;
- Ohnishi, Shunsuke;
- Nakamura, Akihisa;
- Yamada, Ren;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Natsuizaka, Mitsuteru;
- Nakai, Masato
Publication type:
Article
Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma.
Published in:
Cancers, 2022, v. 14, n. 1, p. 232, doi. 10.3390/cancers14010232
By:
- Yang, Zijian;
- Suda, Goki;
- Maehara, Osamu;
- Ohara, Masatsugu;
- Yoshida, Sonoe;
- Hosoda, Shunichi;
- Kimura, Megumi;
- Kubo, Akinori;
- Tokuchi, Yoshimasa;
- Fu, Qingjie;
- Yamada, Ren;
- Kitagataya, Takashi;
- Suzuki, Kazuharu;
- Kawagishi, Naoki;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Morikawa, Kenichi;
- Ogawa, Koji;
- Ohnishi, Shunsuke
Publication type:
Article
Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI.
Published in:
Cancers, 2021, v. 13, n. 14, p. 3633, doi. 10.3390/cancers13143633
By:
- Kubo, Akinori;
- Suda, Goki;
- Kimura, Megumi;
- Maehara, Osamu;
- Tokuchi, Yoshimasa;
- Kitagataya, Takashi;
- Ohara, Masatsugu;
- Yamada, Ren;
- Shigesawa, Taku;
- Suzuki, Kazuharu;
- Kawagishi, Naoki;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Morikawa, Kenichi;
- Ogawa, Koji;
- Ohnishi, Shunsuke;
- Sakamoto, Naoya
Publication type:
Article
Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma.
Published in:
PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0247728
By:
- Shigesawa, Taku;
- Suda, Goki;
- Kimura, Megumi;
- Maehara, Osamu;
- Tokuchi, Yoshimasa;
- Kubo, Akinori;
- Yamada, Ren;
- Furuya, Ken;
- Baba, Masaru;
- Kitagataya, Takashi;
- Suzuki, Kazuharu;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Nakai, Masato;
- Sho, Takuya;
- Natsuizaka, Mitsuteru;
- Morikawa, Kenichi;
- Ogawa, Koji;
- Sakamoto, Naoya
Publication type:
Article
Impact of body mass index on the prognosis of unresectable HCC patients receiving first‐line Lenvatinib or atezolizumab plus bevacizumab.
Published in:
Liver International, 2024, v. 44, n. 5, p. 1108, doi. 10.1111/liv.15885
By:
- Rimini, Margherita;
- Stefanini, Bernardo;
- Tada, Toshifumi;
- Suda, Goki;
- Shimose, Shigeo;
- Kudo, Masatoshi;
- Finkelmeier, Fabian;
- Yoo, Changhoon;
- Presa, José;
- Amadeo, Elisabeth;
- genovesi, Virginia;
- De Grandis, Maria Caterina;
- Iavarone, Massimo;
- Marra, Fabio;
- Foschi, Francesco;
- Tamburini, Emiliano;
- Rossari, Federico;
- Vitiello, Francesco;
- Bartalini, Linda;
- Soldà, Caterina
Publication type:
Article
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.
Published in:
Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 522, doi. 10.1159/000537915
By:
- Rossari, Federico;
- Tada, Toshifumi;
- Suda, Goki;
- Shimose, Shigeo;
- Kudo, Masatoshi;
- Yoo, Changhoon;
- Cheon, Jaekyung;
- Finkelmeier, Fabian;
- Lim, Ho Yeong;
- Presa, José;
- Masi, Gianluca;
- Bergamo, Francesca;
- Amadeo, Elisabeth;
- Vitiello, Francesco;
- Kumada, Takashi;
- Sakamoto, Naoya;
- Iwamoto, Hideki;
- Aoki, Tomoko;
- Chon, Hong Jae;
- Himmelsbach, Vera
Publication type:
Article
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib.
Published in:
Liver Cancer (2235-1795), 2024, v. 13, n. 2, p. 215, doi. 10.1159/000534127
By:
- Iavarone, Massimo;
- Alimenti, Eleonora;
- Tada, Toshifumi;
- Shimose, Shigeo;
- Suda, Goki;
- Yoo, Changhoon;
- Soldà, Caterina;
- Piscaglia, Fabio;
- Tosetti, Giulia;
- Marra, Fabio;
- Vivaldi, Caterina;
- Conti, Fabio;
- Schirripa, Marta;
- Iwamoto, Hideki;
- Sho, Takuya;
- Lee, So Heun;
- Rizzato, Mario Domenico;
- Tonnini, Matteo;
- Rimini, Margherita;
- Campani, Claudia
Publication type:
Article
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000527759
By:
- Hosoda, Shunichi;
- Suda, Goki;
- Sho, Takuya;
- Ogawa, Koji;
- Kimura, Megumi;
- Yang, Zijian;
- Yoshida, Sonoe;
- Kubo, Akinori;
- Tokuchi, Yoshimasa;
- Kitagataya, Takashi;
- Maehara, Osamu;
- Ohnishi, Shunsuke;
- Nakamura, Akihisa;
- Yamada, Ren;
- Ohara, Masatsugu;
- Kawagishi, Naoki;
- Natsuizaka, Mitsuteru;
- Nakai, Masato;
- Morikawa, Kenichi;
- Furuya, Ken
Publication type:
Article
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study.
Published in:
Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 527, doi. 10.1159/000525145
By:
- Casadei-Gardini, Andrea;
- Rimini, Margherita;
- Kudo, Masatoshi;
- Shimose, Shigeo;
- Tada, Toshifumi;
- Suda, Goki;
- Goh, Myung Ji;
- Jefremow, Andre;
- Scartozzi, Mario;
- Cabibbo, Giuseppe;
- Campani, Claudia;
- Tamburini, Emiliano;
- Tovoli, Francesco;
- Ueshima, Kazuomi;
- Aoki, Tomoko;
- Iwamoto, Hideki;
- Torimura, Takuji;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Atsukawa, Masanori
Publication type:
Article
Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-019-56947-1
By:
- Ogawa, Koji;
- Kobayashi, Takashi;
- Furukawa, Jun-ichi;
- Hanamatsu, Hisatoshi;
- Nakamura, Akihisa;
- Suzuki, Kazuharu;
- Kawagishi, Naoki;
- Ohara, Masatsugu;
- Umemura, Machiko;
- Nakai, Masato;
- Sho, Takuya;
- Suda, Goki;
- Morikawa, Kenichi;
- Baba, Masaru;
- Furuya, Ken;
- Terashita, Katsumi;
- Kobayashi, Tomoe;
- Onodera, Manabu;
- Horimoto, Takahiro;
- Shinada, Keisuke
Publication type:
Article

Found: 89